Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Conmed Corp gives Q1 2014 guidance; revenue guidance above analysts' estimates; gives FY 2014 guidance in line with analysts' estimates


Thursday, 13 Feb 2014 07:00am EST 

Conmed Corp:Expects Q1 2014 sales in the range of $191 million to $196 million.Expects Q1 2014 adjusted earnings per share between $0.45 and $0.49.Expects FY 2014 sales in the range of $770 million to $780 million.Expects FY 2014 adjusted earnings per share (EPS) between $1.90 and $2.00.Q1 2014 revenue of $189 million and EPS of $0.45 - Thomson Reuters I/B/E/S.FY 2014 revenue of $773 million and EPS of $1.93 - Thomson Reuters I/B/E/S. 

Company Quote

41.03
1.01 +2.52%
24 Oct 2014